Diprospan Indications/Uses

DIPROSPAN Suspension is indicated for the treatment of acute and chronic corticosteroid-responsive disorders. Corticosteroid hormone therapy is an adjunct to, and not a replacement for, conventional therapy.
Musculoskeletal and Soft Tissue Conditions: Rheumatoid arthritis; osteoarthritis; bursitis; ankylosing spondylitis; epicondylitis; radiculitis; coccydynia; sciatica; lumbago; torticollis; ganglion cyst; exostasis; fasciitis.
Allergic Conditions: Chronic bronchial asthma (including adjunctive therapy for status asthmaticus); hay fever; angioneurotic edema; allergic bronchitis; seasonal or perennial allergic rhinitis; drug reactions; serum sickness; insect bites.
Dermatologic Conditions: Atopic dermatitis (nummular eczema); neurodermatitis (circumscribed lichen simplex); contact dermatitis; severe solar dermatitis; urticaria; hypertrophic lichen planus; necrobiosis lipoidica diabeticorum; alopecia areata; discoid lupus erythematosus; psoriasis; keloids; pemphigus; dermatitis herpetiformis; cystic acne.
Collagen Diseases: Disseminated lupus erythematosus; scleroderma; dermatomyositis; periarteritis nodosa.
Neoplastic Diseases: For palliative management of leukemias and lymphomas in adults; acute leukemia of childhood.
Other Conditions: Adrenogenital syndrome; ulcerative colitis; regional ileitis; sprue; podiatric conditions (bursitis under heloma durum, hallux rigidus, digiti quinti varus); affections requiring subconjunctival injection; corticosteroid-responsive blood dyscrasias; nephritis, and nephrotic syndrome.
Primary and secondary adrenocortical insufficiency may be treated with DIPROSPAN Suspension but should be supplemented with mineralocorticosteroids, if applicable.
DIPROSPAN Suspension is recommended for (1) intramuscular injection in conditions responsive to systemic corticosteroids; (2) injection directly into the affected soft tissues where indicated; (3) intra-articular and periarticular injection in arthritides; (4) intralesional injection in various dermatologic conditions; and (5) local injection in certain inflammatory and cystic disorders of the foot.